Cargando…
Anti N-Methyl-D-Aspartate receptor antibody associated Acute Demyelinating Encephalomyelitis in a patient with COVID-19: a case report
BACKGROUND: Anti N-Methyl-D-Aspartate (NMDA) receptor antibody associated ADEM is a diagnosis that was first described relatively recently in 2007 by Dalmau et al. The recent COVID-19 pandemic has resulted in multiple neurological complications being reported. However, there is limited data on Anti-...
Autores principales: | Naidu, Kuven, Tayler, Rory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273631/ https://www.ncbi.nlm.nih.gov/pubmed/37322555 http://dx.doi.org/10.1186/s13256-023-03979-x |
Ejemplares similares
-
Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report
por: Waschbisch, Anne, et al.
Publicado: (2014) -
Overlapping demyelinating syndrome and anti-N-methyl-d-aspartate receptor encephalitis with seizures
por: Taraschenko, Olga, et al.
Publicado: (2019) -
Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review
por: Zhang, Shujiang, et al.
Publicado: (2022) -
Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Diffuse Demyelinating Plaques: A Case Report of an Atypical Presentation
por: Tirado-García, Luis-Angel, et al.
Publicado: (2023) -
Acute Mechanisms Underlying Antibody Effects in Anti–N-Methyl-D-Aspartate Receptor Encephalitis
por: Moscato, Emilia H, et al.
Publicado: (2014)